Reported Uptake of the Centers for Disease Control and Prevention's Controlling High Blood Pressure and Controlling High Cholesterol Indicators among State Heart Disease and Stroke Prevention Programs by Weir, Aaron Joseph
 REPORTED UPTAKE OF THE CENTERS FOR DISEASE CONTROL AND 
PREVENTION’S CONTROLLING HIGH BLOOD PRESSURE AND CONTROLLING 
HIGH CHOLESTEROL INDICATORS AMONG STATE HEART DISEASE AND 










Aaron Joseph Weir 









Submitted to the Graduate Faculty of 
Graduate School of Public Health in partial fulfillment  
of the requirements for the degree of 














UNIVERSITY OF PITTSBURGH 
 
Graduate School of Public Health 
 
 




Aaron Joseph Weir 
 
It was defended on 
 
April 7, 2011 
 
and approved by 
 
Thesis Advisor: 
Bath AD Nolan, PhD 
Assistant Professor 
Department of Behavioral and Community Health Sciences 
Graduate School of Public Health 
University of Pittsburgh 
 
Committee Member: 
Steven M. Albert, PhD, MSPH, MA 
Professor 
Associate Chair for Research and Science 
Department of Behavioral and Community Health Sciences 
Graduate School of Public Health 
University of Pittsburgh 
 
Committee Member: 
Constance M. Bayles, PhD 
Assistant Clinical Professor 
Department of Epidemiology 
Graduate School of Public Health 
University of Pittsburgh 
 
 iii 
Copyright © by Aaron Joseph Weir 
2011 
 iv 
Beth AD Nolan, PhD 
REPORTED UPTAKE OF THE CENTERS FOR DISEASE CONTROL AND 
PREVENTION’S CONTROLLING HIGH BLOOD PRESSURE AND CONTROLLING HIGH 




Aaron Joseph Weir, MPH 
 
University of Pittsburgh, 2011 
 
Objective:  
This descriptive research describes the reported uptake of the Centers for Disease Control and 
Prevention’s (CDC) Controlling High Blood Pressure and Controlling High Cholesterol 
Indicators among funded state programs for heart disease and stroke prevention.  The Indicators 
serve as evidence-based performance measures which aim to streamline the implementation and 
evaluation of the National Heart Disease and Stroke Prevention Program. 
Methods:  
Participants included 42 state health departments funded by the CDC for heart disease and stroke 
prevention initiatives.  Fourteen states were funded as Basic Implementation programs (to 
implement and evaluate interventions) and 28 states were funded as Capacity Building programs 
(to enhance capacity for implementing interventions).  Documentation of Indicator uptake was 
extracted from the 2009-2010 and 2010-2011 Work Plans for all funded programs.   
Results:  
In general, all programs increased their reported uptake of Indicators over time.  On average, 
from 2009 to 2011, Basic Implementation programs reported more Indicators per Work Plan 




While this study provides documentation of the uptake of Indicators in Work Plans, a subsequent 
analysis should research if the appropriate use of Indicators as a performance measure improves 
documentation of the actual reach and impact for heart disease and stroke interventions. 
Implications for Public Health: 
The public health significant of this work includes the following contributions to the public 
health field include: (a) providing guidance to state programs, (b) visualizing the trends and 
patterns in the reported use of Indicators for Controlling High Blood Pressure and Controlling 
High Cholesterol among state programs, (c) encouraging accountability, and (d) sharing the 
strengths and/or areas for improvement with state programs to foster better programming and 
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PREFACE 
This descriptive research project was completed during an internship with the Centers for 
Disease Control and Prevention (CDC) in Atlanta, Georgia during the summer of 2010.  The 
core purpose of the project was to describe the uptake of CDC performance measures (known as 
Indicators) into state health department Work Plans that were aimed at impacting heart disease 
and stroke.  To protect confidentiality, any identifying information pertaining to state health 
departments has been removed from this document and replaced with an arbitrary alias.   
I owe many thanks and acknowledgments to my mentors from both the University of 
Pittsburgh (including but not limited to Dr. Beth Nolan, Dr. Steven Albert, and Dr. Constance 
Bayles) and the CDC (including Lazette Lawton, Richard Sullivan, Eileen Chappelle, Hilary 
Wall, and the entire Program Development and Services Branch of the Division for Heart 
Disease and Stroke Prevention).  Each of these individuals has truly expanded my academic and 
professional horizons.  I have learned, and continue to learn, a great deal with each and every 
interaction that we share.  Most importantly, I’d like to thank my parents, Kenneth and Loretta 
Weir, for providing me with a foundation for success and for encouraging me to pursue such 
ambitious plans with my life.  My parents have always made sacrifices to support my education.  
Without their love and support, I would not be where I am today.   
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1.0  INTRODUCTION 
1.1 THE BURDEN OF HEART DISEASE AND STROKE 
Cardiovascular diseases (CVDs), particularly heart disease and stroke, are among the leading 
causes of death nationwide and worldwide for both men and women of all racial and ethnic 
groups 1,2.  In the United States, heart disease and stroke are the first and third leading causes of 
death, respectively 2.  More than 80 million Americans, or about one in three adults, have some 
form of CVD, including high blood pressure (hypertension), coronary heart disease, congestive 
heart failure, stroke, and others 1.    Nearly one million Americans suffer a heart attack each year 
and, of them, approximately 38% die 2.  Nearly 800,000 others suffer a stroke each year; one in 
every four of these individuals dies 1.  With such high numbers of individuals affected each year, 
the United States is burdened with the staggering costs of treating CVD. 
In 2008, the health care costs for treating coronary heart disease alone were estimated to 
exceed $156 billion 2.  Including health expenditures and lost productivity, CVD cost the United 
States an estimated $475.3 billion in 2009 1.  Currently, more than one million U.S. adults live 
with impairment or disability due to stroke 2.  In the United States workforce, heart disease and 
stroke are the leading causes of premature, permanent, and long-term disability 2.   
Racial health disparities are also pronounced.  Age-adjusted death rates from heart 
disease were 32% higher for African Americans than for Caucasians in 2005 2.  Today, heart 
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disease and stroke are killing more young people, aged 15 to 34, than ever before.  Women are 
dying from heart disease at a much higher rate than they are from breast cancer; about 219 
women per 100,000 die annually of heart disease, compared with 27 per 100,000 who die of 
breast cancer 2.  However, scientific evidence has shown that primary and secondary prevention 
can save the lives of many individuals.  Evidence-based research suggests that, using population-
based approaches to health education and promotion, public health officials can develop 
promising interventions to improve cardiovascular health nationwide 2.  In 2006, this evidence 
contributed to the creation of the Center for Disease Control and Prevention’s (CDC’s) Division 
for Heart Disease and Stroke Prevention (DHDSP). 
1.2 THE DIVISION FOR HEART DISEASE AND STROKE PREVENTION 
The mission of the DHDSP is “to serve as the nation's public health leader for achieving 
cardiovascular health for all and for eliminating disparities in the burden of heart disease and 
stroke.”3 The DHDSP funds the National Heart Disease and Stroke Prevention Program 
(NHDSPP) to support state health departments in managing heart disease and stroke prevention 
programs at the state and local levels.  Currently, 42 states (this includes the District of 
Columbia, but not Puerto Rico and the Virgin Islands) are funded; 28 for Capacity Building and 
14 for Basic Implementation (see 2.1 Participating States).    
Through the use of public health data and resources, the DHDSP reaches nationwide to 
build upon valued relationships and translate evidence-based strategies and proven science into 
action.  The overarching goals of the DHDSP are to: (a) prevent risk factors for heart disease and 
stroke; (b) increase detection and treatment of risk factors; (c) increase early detection and 
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treatment of heart disease and stroke; (d) decrease recurrences of heart attacks and strokes; and 
(e) foster a skilled and engaged public health workforce 3.  To accomplish the above goals, the 
DHDSP funds 42 health departments to support initiatives for heart disease and stroke 
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2.0  METHODOLOGY 
2.1 PARTICIPATING STATES 
States funded by the CDC for heart disease and stroke prevention promote policy and systems 
change, primarily in health care, workplace, and community settings.  In particular, state 
programs focus on controlling high blood pressure and high cholesterol, increasing awareness of 
heart attack and stroke signs and symptoms, the importance of calling 9-1-1 in an emergency 
situation related to heart attack and stroke, enhancing emergency response and the quality of 
health care delivered, and narrowing health disparities among high-risk populations.   
All funded programs receive funding for approximately five years, contingent upon the 
program’s ability to document satisfactory performance.  Performance measures, or Indicators, 
were identified by DHDSP personnel; These Indicators, which are the object of analyses for this 
article, are used to keep every program’s objectives in line with the DHDSP and to document 
measures for the evaluation of the National Heart Disease and Stroke Prevention Program 
(NHDSPP).   
As previously mentioned, there are two types of funded programs for the NHDSPP: Basic 
Implementation Programs and Capacity Building Programs.  Basic Implementation Programs 
and Capacity Building Programs differ according to funding levels and performance 
expectations.  However, both programs use the same performance measures, or Indicators, to 
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inform and evaluate program services. Figure 1 provides a visualization of funded programs 
nationwide, which are broken down according to funding type (discussed in detail in sections 
2.1.1 Basic Implementation Programs and 2.1.2 Capacity Building Programs).   
 
Figure 1 Participating States, 2009-2011 
2.1.1 Basic Implementation Programs 
Basic Implementation programs develop, disseminate, and evaluate heart disease and stroke 
prevention intervention activities that are appropriate for each program’s objectives.  From 2009 
to 2011, the two priority areas of evaluation interest are: (a) increasing control of high blood 
pressure, primarily in adults and older adults and (b) increasing control of high blood cholesterol, 
primarily in adults and older adults 4.  These programs receive higher amounts of funding in 
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order to support the implementation and evaluation processes associated with the interventions.  
The Funding Opportunity Announcement which employs these programs (FOA DP07-704) 
determines which state programs possess the necessary capacities for the execution of such 
interventions and funds these states for Basic Implementation purposes.  Other funded states, 
which require more capacities, are funded for Capacity Building purposes (discussed in 2.1.2 
Capacity Building Programs) 
Basic Implementation programs are charged with: (a) enhancing all capacity building 
activities, (b) implementing and evaluating policy, systems change, and educational interventions 
that address heart disease and stroke priority areas, and (c) providing training and technical 
assistance to public health and healthcare providers to support policy and systems change.  In 
essence, a basic implementation program is designed to extend existing capacity building 
activities as well as deliver and evaluate interventions. In 2009, 14 states received funding as 
Basic Implementation Programs for five years, contingent upon satisfactory performance as 
deemed by the CDC.  
2.1.2 Capacity Building Programs 
Capacity Building programs use partnership development, burden identification and definition, 
and state plan development to create the basis for a wide-scale CVD prevention program.  These 
programs receive less funding than Basic Implementation programs.  However, like Basic 
Implementation programs, the two priority areas of evaluation interest from 2009 to 2011 are: (a) 
increasing control of high blood pressure, primarily in adults and older adults and (b) increasing 
control of high blood cholesterol, primarily in adults and older adults 4.   
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Capacity Building programs are responsible for: (a) facilitating collaboration with public- 
and private-sector partners, (b) documenting the burden of heart disease, stroke, and risk factors 
in their state, (c) developing plans for population-based approaches for preventing heart disease 
and stroke among general and priority populations, (d) developing a state plan, (e) developing a 
logic model and evaluation plan, and (f) assessing the assets and gaps in state policy and systems 
related to heart disease and stroke prevention in healthcare, worksite, and community settings.  
Essentially, a capacity building program is designed to develop the foundation for a 
comprehensive CVD prevention program.  In 2009, 28 states received funding as Capacity 
Building Programs for five years, contingent upon satisfactory performance as deemed by the 
CDC.  
No states were awarded funding for both Basic Implementation and Capacity Building.  
Thus, 42 out of 50 states were funded for either Basic Implementation or Capacity Building in 
2009.  Upon funding, programs received technical assistance from the DHDSP which provided 
guiding models and related Indicators (performance measures) to be used for program planning, 
implementation, and evaluation. 
2.2 MEASURES 
2.2.1 Indicators and Logic Models 
The DHDSP created logic models for Controlling High Blood Pressure 5 (Appendix B) and 
Controlling High Cholesterol 6 (Appendix C) which were informed by the Social-Ecological 
Model, first described by McLeroy, Bibeau, Steckler, and Glanz in 1988 7.  The logic models 
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were designed to guide intervention objectives and align all 42 funded programs with the 
common goals of the DHDSP (outlined in 1.2 The Division for Heart Disease and Stroke 
Prevention).  The Social-Ecological Model depicts society as a web of interconnected factors that 
affect one another.  It indicates that, in order to change individual behavior, an effective 
intervention must take into account the multiple levels of influence over health behavior – 
intrapersonal factors, interpersonal processes and primary groups, organizational or institutional 
factors, community factors, and public policy 7.  Based on previous successes in helping to 
reverse the tobacco use epidemic, there is evidence to support the use of the Social-Ecological 
Model to affect the environments and policies that drive factors influencing cardiovascular 
health7.  Policy and environmental changes broaden the options for public health interventions.  
In contrast to interventions that only affect individuals who choose to participate, policy 
interventions can affect virtually entire populations 7.  Therefore, funded state HDSP programs 
are geared towards identifying culturally competent, population-based strategies to reduce the 
morbidity, mortality, and costs associated with heart disease and stroke.  Accordingly, the focus 
of the DHDSP is to involve state programs in the societal and community levels of the Social-
Ecological Model via policy and systems-level changes 2.  For example, many state programs 
choose to impact worksite health by increasing the number of evidence-based quality 
improvement initiatives to increase practitioner compliance with Joint National Committee 7 
(JNC 7) treatment guidelines for controlling high blood pressure.  
Every logic model box for both Controlling High Blood Pressure and Controlling High 
Cholesterol includes Indicators (performance measures) that are supported by scientific evidence 
to impact heart disease and stroke 8, 9.  A numeric system is used to simplify and organize the list 
of 120 different Indicators that the DHDSP provides to the programs (see Figure 2 for visual). 
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The first number in each Indicator denotes the logic model from which it originated (1 = 
Controlling High Blood Pressure, 2 = Controlling High Cholesterol).  The second number 
indicates which box on the logic model that the Indicator relates to (this ranges from 1 to 11).  
Finally, the third number identifies a specific performance measure that corresponds to the 
identified logic model box.  Essentially, the logic models depict the flow of the NHDSPP (with 
the underlying theory being the Social-Ecological Model) and the Indicators are performance 
measures that can be used to impact the various domains (logic model boxes) on each logic 
model.  In encouraging the use of Indicators, the DHDSP can better understand and evaluate the 
efforts put forth by each funded program. 
 
Figure 2  Indicator Number Designation 
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Each Indicator was selected after an extensive CDC review process.  Every potential 
Indicator was rated by CDC personnel experts on a scale based off of existing science, expert 
opinion, and state practices.  For example, rating measures included: overall quality (low to 
high), resources needed (low to high), scientific evidence (five-point Likert scale), face validity 
(five-point Likert scale), utility (five-point Likert scale), and accepted practice (five-point Likert 
scale) 8, 9.  Indicators were created in a way that any state program could utilize them, discussed 
below. 
To facilitate uptake into state HDSP programs, Indicators and supporting materials were 
written to allow for flexibility so that programs can tailor performance measures to the specific 
strategies and needs of the program; in other words, the Indicators are general performance 
measures rather than rigid, concrete measures.  In total, the DHDSP identified 63 Controlling 
High Blood Pressure Indicators (spanning 11 logic model boxes from short- to long-term 
outcomes) and 57 Controlling High Cholesterol Indicators (spanning 11 logic model boxes from 
short- to long-term outcomes) for a total of 120 different Indicators (see Appendix A for a full, 
descriptive list of the Indicators).  To provide a clearer focus for state programs when choosing 
Indicators to impact with interventions, the DHDSP selected a smaller subset of Indicators, 
called Core Indicators, to target key areas for heart disease and stroke prevention. 
2.2.1.1 Core Indicators 
The DHDSP identified a set of Core Indicators from the list of Controlling High Blood Pressure 
and Controlling High Cholesterol Indicators.  These Core Indicators were selected based on the 
quality of the evidenced-based research which supports their use for impacting heart disease and 
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stroke.  In total, there are 11 Core Indicators for Controlling High Blood Pressure and 13 Core 
Indicators for Controlling High Cholesterol. 
 
 
2.2.2 The Heart Disease and Stroke Prevention Management Information System 
All of the data used in this analysis were extracted from the Heart Disease and Stroke Prevention 
Management Information System (HDSP MIS).  The HDSP MIS is an electronic system that 
state health departments access to submit and update Work Plans so that the DHDSP can monitor 
the documentation of state activities related to heart disease and stroke prevention and provide 
technical assistance.  Each funded state health department designates staff members who submit 
the information on a bi-annual basis; these individuals typically hold leadership/management 
positions in the health department.   
Work Plans are the means by which the DHDSP maintains an ongoing record of state 
HDSP programs’ interventions.  The submission of Work Plans into HDSP MIS serves several 
functions for the DHDSP including to: (a) provide a comprehensive view of each state program 
as well as the national program (the NHDSPP), (b) standardize reporting across all states, (c) 
improve the documentation of program successes and challenges, (d) indentify promising 
practices, and (e) facilitate program evaluation 2.  In the HDSP MIS, each state reports capacity 
building objectives, intervention objectives, a core components summary related to their HDSP 
program activities (including key partners, key contractors, the state plan, a burden report, data 
sources, a policy and environmental assessment, and capacity building training and technical 
assistance), and an overall Work Plan summary that captures the range of interventions that are 
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planned or ongoing which impact heart disease and stroke. In the bi-annual Work Plans, state 
HDSP programs are requested to parenthetically document Indicators that are impacted by their 
planned activities or interventions. Often, states document Indicators in the intervention 
objectives statement, which is a concise snapshot of the planned or ongoing intervention(s).  For 
example, in one state’s Work Plan summary, three Indicators were parenthetically documented 
as being impacted by the planned activity in the intervention objectives statement in the 
following manner: “Conduct statewide blood pressure campaigns in English, Spanish, and 
Portuguese.  (Anticipated CDC HBP indicators: 1.5.1, 1.5.3, 1.5.6).” 10 Using the HDSP MIS as 
the basis for reporting Indicator uptake, analyses were conducted to describe changes in the 
reported uptake of Controlling High Blood Pressure Indicators and Controlling High Cholesterol 
Indicators among Basic Implementation Programs and Capacity Building Programs from the 
2009-2010 Work Plans to the 2010-2011 Work Plans. 
2.3 ANALYSIS 
Two Microsoft Excel databases 11, 12 were constructed in order to document the frequency of 
reported Indicator usage for Controlling High Blood Pressure and Controlling High Cholesterol.  
One database was formed for a 2009-2010 Work Plan analysis 11 and another for a 2010-2011 
Work Plan analysis 12.  Since the NHDSPP distinguishes state HDSP programs as either 
Capacity Building or Basic Implementation, two separate spreadsheets were created within each 
database – one for each funding category.  Every Indicator for Controlling High Blood Pressure 
and Controlling High Cholesterol was represented in the spreadsheet along with running totals 
within each state and across all states of the same funding-type. 
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As previously mentioned, state HDSP programs are asked to report appropriate Indicators 
of their choosing to their planned activities in their bi-annual Work Plans.  The reporting of 
Indicator uptake is critical information because it allows the DHDSP to: (a) provide guidance 
and technical assistance to the states, (b) describe trends and patterns in reported state activities 
linked to Controlling High Blood Pressure and Controlling High Cholesterol Indicators, (c) 
encourage accountability (a core value of the DHDSP), and (d) recognize strengths and/or areas 
for program improvement.   
Each Work Plan was manually analyzed to document the specific, parenthetical 
documentation of an Indicator.  For example, one state’s intervention objective in a 2010-2011 
Work Plan summary stated, “Implementation of Worksite Wellness Model (2.3.2, 2.3.3, 2.3.4, 
1.3.3, 1.3.4, 1.3.6). By 06/2011, increase the percentage of employees participating in a worksite 
wellness initiative at a pilot worksite from 0% to 30% within the work site setting (Influencing 
the general population).” 10 In this example, the numbers listed in parentheses were indications 
of what Indicators the state was using.  After the intervention objectives, state Work Plans would 
elaborate on the intervention by providing a brief summary related to that intervention’s key 
partners, key contractors, state plan, burden report, data sources, policy and environmental 
assessments, and capacity building training and technical assistance (these were all supplemental 
details to the interventions that were not used in this analysis but could be used to justify the 
selection of the Indicators chosen).  Accordingly, in the appropriate Excel database (in this case, 
2010-2011), the Indicators were tallied under that state along with a description of each Indicator 
for quick reference.  In the example above, the database read, “2.3.2: Proportion of worksites 
that offer behavioral approaches for employees to control high cholesterol”. 12 This process was 
repeated for all 42 funded HDSP programs for both the 2009-2010 and 2010-2011 Work Plans.  
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If a state did not explicitly write out the Indicator impacted by an intervention, it was not 
included in the analysis.  In other words, no assumptions were made about the impact that any 
intervention would have on an Indicator unless the Work Plan explicitly reported the Indicator 
with the intervention.  Subsequently, the data was cleaned by double-checking for data entry 
errors and prepared for descriptive analysis.   
2.3.1 Analyses Performed 
The following descriptive analyses were performed on each report separately (2009-2010 Work 
Plans and 2010-2011 Work Plans) and then analyzed for longitudinal trends in reported Indicator 
uptake across state all 42 funded HDSP programs: 
2.3.1.1 Average Number of Indicators Reported per Work Plan 
For both the 2009-2010 and 2010-2011 Work Plans, the average number of Controlling High 
Blood Pressure and Controlling High Cholesterol Indicators per Work Plan were tallied for Basic 
Implementation and Capacity Building Programs.  In addition, an “only non-zero analysis” was 
included to describe the average number of Indicators reported per Work Plan among only the 
programs that reported at least one Indicator in a Work Plan.  This was done to analyze the 
uptake of Indicators over time among only those Programs that consistently reported Indicator 
uptake (see 3.1 Average Number of Indicators Reported per Work Plan).  
2.3.1.2 Most Frequently Reported Indicators 
To better visualize trends in the types of Indicators that were reported most often over time, a 
count of reported Indicators was conducted among Basic Implementation and Capacity Building 
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Programs for the 2009-2010 and 2010-2011 Work Plans (see 3.2 Most Frequently Reported 
Indicators). 
2.3.1.3 Reported Indicator Uptake by Program Type 
An analysis of reported Indicator uptake (the combination of all Indicators, both Controlling 
High Blood Pressure and Controlling High Cholesterol) for the 2009-2010 and 2010-2011 Work 
Plans was conducted for each funded program to document change in reported uptake over time.  
Each analysis compared each program’s 2009-2010 Work Plan to the same program’s 2010-2011 
Work Plan to document change in reported uptake (see 3.3 Reported Indicator Uptake by 
Program Type). 
2.3.1.4 Reported Uptake of Controlling High Blood Pressure Indicators by Program Type 
An analysis of reported Controlling High Blood Pressure Indicator uptake for the 2009-2010 and 
2010-2011 Work Plans was conducted for each funded program to document change in reported 
uptake over time.  Each analysis compared each program’s 2009-2010 Work Plan to the same 
program’s 2010-2011 Work Plan to document change in reported uptake of only Controlling 
High Blood Pressure Indicators (see 3.4 Reported Uptake of Controlling High Blood Pressure 
Indicators by Program Type). 
2.3.1.5 Reported Uptake of Controlling High Cholesterol Indicators by Program Type 
An analysis of reported Controlling High Cholesterol Indicator uptake for the 2009-2010 and 
2010-2011 Work Plans was conducted for each funded program to document change in reported 
uptake over time.  Each analysis compared each program’s 2009-2010 Work Plan to the same 
program’s 2010-2011 Work Plan to document change in reported uptake of only Controlling 
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High Cholesterol Indicators (see 3.5 Reported Uptake of Controlling High Cholesterol Indicators 
by Program Type). 
2.3.1.6 Reported Uptake of Core Indicators by Priority Area 
For both Basic Implementation and Capacity Building Programs, the total reported uptake of 
Core Indicators for the 2009-2010 and 2010-2011 Work Plans was calculated and graphed in 
order to visualize temporal changes in reported Core Indicator uptake.  Two graphical 
representations were created: one for reported uptake of Controlling High Blood Pressure Core 
Indicators and one for reported uptake of Controlling High Cholesterol Core Indicators (see 3.6 
Reported Uptake of Core Indicators by Priority Area). 
2.3.1.7 Variation of Reported Indicator Uptake 
An analysis was conducted to determine the percentage of the 120 total Indicators provided by 
the DHDSP that were reported in Work Plans over time.  This analysis documented the breadth 
of reported Indicator uptake to identify what percent of all possible Indicators were reported over 
time (see 3.7 Variation of Reported Indicator Uptake). 
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3.0  RESULTS 
In order to describe the reported uptake of Controlling High Blood Pressure and Controlling 
High Cholesterol Indicators among Basic Implementation and Capacity Building Programs, a 
descriptive data analysis was performed with the information collected from the HDSP MIS 
2009-2010 and 2010-2011 Work Plans.  It was hypothesized that reported uptake of Indicators 
would increase over time for both Basic Implementation and Capacity Building Programs.  More 
frequent reporting of Core Indicator uptake over time was also anticipated.   
The results are split into various categories based on the type of analysis performed (see 
2.3.1 Analysis Performed).  Each analysis appropriately breaks down the information into some 
or all of the following categories depending on the type of analysis performed: All Funded 
Programs (n=42), Capacity Building Programs (n=28), or Basic Implementation Programs 
(n=14). 
3.1 AVERAGE NUMBER OF INDICATORS REPORTED PER WORK PLAN 
3.1.1 All Programs (n=42) 
From the 2009-2010 Work Plans to the 2010-2011 Work Plans, the average number of 
Controlling High Blood Pressure Indicators reported increased by 1.1 Indicators per Work Plan.  
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Controlling High Cholesterol Indicators reported increased by 1.2 Indicators per Work Plan.  
Overall, the average number of Indicators reported per program increased by 2.3 Indicators per 
Work Plan from the 2009-2010 to the 2010-2011 Work Plans (see Table 1). 
3.1.1.1 All Programs: 2009-2010 Work Plan Only Non-Zero Analysis 
In only those 2009-2010 Work Plans that reported at least one Controlling High Blood Pressure 
Indicator (n=30), there was an average of 4.6 Indicators reported per Work Plan.  In only those 
2009-2010 Work Plans that reported at least one Controlling High Cholesterol Indicator (n=20), 
there was an average of 3.1 Indicators reported per Work Plan.  In only those 2009-2010 Work 
Plans that reported at least one type (any type) of Indicator (n=30), there was an average of 6.7 
Indicators reported per Work Plan (see Table 1). 
3.1.1.2 All Programs: 2010-2011 Work Plan Only Non-Zero Analysis 
In only those 2010-2011 Work Plans that reported at least one Controlling High Blood Pressure 
Indicator (n=37), there was an average of 5.0 Indicators reported per Work Plan.  In only those 
2010-2011 Work Plans that reported at least one Controlling High Cholesterol Indicator (n=31), 
there was an average of 3.7 Indicators reported per Work Plan.  In only those 2010-2011 Work 
Plans that reported at least one type (any type) of Indicator (n=37), there was an average of 8.0 
Indicators reported per Work Plan (see Table 1).  
3.1.2 Basic Implementation Programs (n=14) 
From the 2009-2010 Work Plans to the 2010-2011 Work Plans, the average number of 
Controlling High Blood Pressure Indicators reported increased by 2.6 Indicators per Work Plan.  
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The average number of Controlling High Cholesterol Indicators reported increased by 2.5 
Indicators per Work Plan.  Overall, the average number of Indicators reported per Basic 
Implementation Program increased by 5.1 Indicators per Work Plan from the 2009-2010 to the 
2010-2011 Work Plans (see Table 1). 
3.1.2.1 Basic Implementation Programs: 2009-2010 Work Plan Only Non-Zero Analysis 
In only those 2009-2010 Basic Implementation Program Work Plans that reported at least one 
Indicator for Controlling High Blood Pressure (n=10), there was an average of 4.9 Indicators 
reported per Work Plan.  Among 2009-2010 Basic Implementation Program Work Plans that 
reported at least one Indicator for Controlling High Cholesterol (n=7) there was an average of 2.9 
Indicators reported per Work Plan. In only those 2009-2010 Basic Implementation Program 
Work Plans that listed at least one type (any type) of Indicator (n=10), there was an average of 
6.9 Indicators reported per Work Plan (see Table 1). 
3.1.2.2 Basic Implementation Programs: 2010-2011 Work Plan Only Non-Zero Analysis 
In only those 2010-2011 Capacity Building Program Work Plans that reported at least one 
Indicator for Controlling High Blood Pressure (n=13), there was an average of 6.5 Indicators 
reported per Work Plan. Among 2010-2011 Basic Implementation Program Work Plans that 
reported at least one Indicator for Controlling High Cholesterol (n=12), there was an average of 
4.6 Indicators reported per Work Plan.  In only those 2010-2011 Basic Implementation Program 
Work Plans that listed at least one type (any type) of Indicator (n=13), there was an average of 
10.8 Indicators reported per Work Plan (see Table 1). 
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3.1.3 Capacity Building Programs (n=28) 
From the 2009-2010 Work Plans to the 2010-2011 Work Plans, the average number of 
Controlling High Blood Pressure Indicators reported increased by .3 Indicators per Work Plan.  
The average number of Controlling High Cholesterol Indicators reported increased by .6 
Indicators per Work Plan.  Overall, the average number of Indicators reported per Capacity 
Building Program increased by .9 Indicators per Work Plan from the 2009-2010 to the 2010-
2011 Work Plans (see Table 1). 
3.1.3.1 Capacity Building Programs: 2009-2010 Work Plan Only Non-Zero Analysis 
In only those 2009-2010 Capacity Building Program Work Plans that reported at least one 
Indicator for Controlling High Blood Pressure (n=20), there was an average of 4.5 Indicators 
reported per Work Plan.  Among 2009-2010 Capacity Building Program Work Plans that 
reported at least one Indicator for Controlling High Cholesterol (n=13), there was an average of 
3.2 Indicators reported per Work Plan.  In only those 2009-2010 Capacity Building Program 
Work Plans that listed at least one type (any type) of Indicator (n=20), there was an average of 
6.6 Indicators reported per Work Plan (see Table 1). 
3.1.3.2 Capacity Building Programs: 2010-2011 Work Plan Only Non-Zero Analysis 
In only those 2010-2011 Capacity Building Program Work Plans that reported at least one 
Indicator for Controlling High Blood Pressure (n=24), there was an average of 4.1 Indicators 
reported per Work Plan.  Among 2010-2011 Capacity Building Program Work Plans that 
reported at least one Indicator for Controlling High Cholesterol (n=19), there was an average of 
3.1 Indicators reported per Work Plan. In only those 2010-2011 Capacity Building Program 
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Work Plans that listed at least one type (any type) of Indicator (n=24), there was an average of 
6.5 Indicators reported per Work Plan (see Table 1). 
 
Table 1 Average Number of Indicators Reported Per Work Plan 
    
All Programs 2009-2010 Work Plan 
2010-2011 
Work Plan Difference 
Average Number of Indicators per Program 4.8 7.1 +2.3 
Average Number of Controlling High Blood 
Pressure Indicators per Program 3.3 4.4 +1.1 
Average Number of Controlling High 
Cholesterol Indicators per Program 1.5 2.7 +1.2 
    
Only Non-Zero Programs 2009-2010 Work Plan 
2010-2011 
Work Plan Difference 
Average Number of Indicators per Program 6.7 8.0 +1.3 
Average Number of Controlling High Blood 
Pressure Indicators per Program 4.6 5.0 +0.4 
Average Number of Controlling High 
Cholesterol Indicators per Program 3.1 3.7 +0.6 
    
All Basic Implementation Programs 2009-2010 Work Plan 
2010-2011 
Work Plan Difference 
Average Number of Indicators per Program 4.9 10.0 +5.1 
Average Number of Controlling High Blood 
Pressure Indicators per Program 3.5 6.1 +2.6 
Average Number of Controlling High 
Cholesterol Indicators per Program 1.4 3.9 +2.5 
    





Work Plan Difference 
Average Number of Indicators per Program 6.9 10.8 +3.9 
Average Number of Controlling High Blood 
Pressure Indicators per Program 4.9 6.5 +1.6 
Average Number of Controlling High 
Cholesterol Indicators per Program 2.9 4.6 +1.7 
    
All Capacity Building Programs 2009-2010 Work Plan 
2010-2011 
Work Plan Difference 
Average Number of Indicators per Program 4.7 5.6 +0.9 
Average Number of Controlling High Blood 
Pressure Indicators per Program 3.2 3.5 +0.3 
Average Number of Controlling High 1.5 2.1 +0.6 
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Cholesterol Indicators per Program 
    





Work Plan Difference 
Average Number of Indicators per Program 6.6 6.5 -0.1 
Average Number of Controlling High Blood 
Pressure Indicators per Program 4.5 4.1 -0.4 
Average Number of Controlling High 
Cholesterol Indicators per Program 3.2 3.1 -0.1 
 
 
3.2 MOST FREQUENTLY REPORTED INDICATORS 
3.2.1 All Programs (n=42) 
Indicators that addressed healthcare systems and workplace changes were denoted most 
frequently among all programs in both the 2009-2010 Work Plans and 2010-2011 Work Plans.    
The most frequently reported Indicators included: 1.1.5, 1.1.3, 1.3.6, 2.1.5, 2.3.4, and 2.3.2.  For 
a more detailed description of all frequently reported Indicators among all programs, see Table 2. 
Table 2  Most Frequently Reported Indicators, All Programs 
   
All Programs 2009-2010 Work Plans 







1.8.1* 11 Proportion of individuals who have achieved blood pressure control 
1.1.5 10 
Number of evidence-based quality improvement initiatives to 
increase practitioner compliance with Joint National Committee 
(JNC) 7 treatment guidelines 
1.1.3* 8 Proportion of healthcare systems with electronic medical records 
Table 1 Continued 
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for high blood pressure control (incl. pharmacologic and lifestyle 
modification components) 
1.3.6* 8 Proportion of workplaces with environmental changes to control high blood pressure 
All Programs 2009-2010 Work Plans 







2.1.5 8 Number of quality improvements to increase practitioner adherence to current evidence-based cholesterol guidelines 
2.3.4* 7 Proportion of worksites with environmental supports to control high cholesterol 
2.3.2 5 Proportion of worksites that offer behavioral approaches for employees to control high cholesterol 
   
All Programs 2010-2011 Work Plans 








Number of evidence-based quality improvement initiatives to 
increase practitioner compliance with Joint National Committee 
(JNC) 7 treatment guidelines 
1.3.6* 13 Proportion of workplaces with environmental changes to control high blood pressure 
1.1.3* 11 
Proportion of healthcare systems with electronic medical records 
for high blood pressure control (incl. pharmacologic and lifestyle 
modification components) 
1.5.1* 11 
Proportion of individuals who are aware of the risks associated 
with uncontrolled high blood pressure (both causes and 
consequences) 
All Programs 2010-2011 Work Plans 







2.1.5 13 Number of quality improvements to increase practitioner adherence to current evidence-based cholesterol guidelines 
2.3.4* 10 Proportion of worksites with environmental supports to control high cholesterol 
2.3.2 9 Proportion of worksites that offer behavioral approaches for employees to control high cholesterol 
Table 2 Continued 
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2.1.2* 8 Proportion of healthcare systems with electronic medical records appropriate for treating patients with high cholesterol 
*Core Indicators  
 
3.2.2 Basic Implementation Programs (n=14) 
Indicators that addressed healthcare systems changes for Controlling High Blood Pressure and 
workplace changes for Controlling High Cholesterol were denoted more frequently among Basic 
Implementation Programs in both the 2009-2010 and 2010-2011 Work Plans.  They included 
Indicators 1.1.5 and 2.3.4.   For a more detailed description of all frequently reported Indicators 
among Basic Implementation Programs, see Table 3. 
 
Table 3  Most Frequently Reported Indicators, Basic Implementation Programs 
   
Basic Implementation Programs 2009-2010 Work Plans 







1.8.1* 5 Proportion of individuals who have achieved blood pressure control 
1.1.5 4 
Number of evidence-based quality improvement initiatives to 
increase practitioner compliance with Joint National Committee 
(JNC) 7 treatment guidelines 
Basic Implementation Programs 2009-2010 Work Plans  







2.3.4* 3 Proportion of worksites with environmental supports to control high cholesterol 
   
Basic Implementation Programs 2010-2011 Work Plans 
Table 2 Continued 
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Number of evidence-based quality improvement initiatives to 
increase practitioner compliance with Joint National Committee 
(JNC) 7 treatment guidelines 
1.3.6* 8 Proportion of workplaces with environmental changes to control high blood pressure 
1.1.8 5 
Proportion of healthcare systems with policies to increase patient 
adherence with hypertension treatment (incl. pharmacologic and 
lifestyle modification components) 
1.2.1 5 Proportion of providers who measure blood pressure according to JNC guidelines 
Basic Implementation Programs 2010-2011 Work Plans  







2.3.4* 7 Proportion of worksites with environmental supports to control high cholesterol 
2.1.5 6 Number of quality improvements to increase practitioner adherence to current evidence-based cholesterol guidelines 
2.3.2 4 Proportion of worksites that offer behavioral approaches for employees to control high cholesterol 
*Core Indicators  
3.2.3 Capacity Building Programs (n=28) 
The most frequently reported Indicators among Capacity Building Programs in both the 2009-
2010 and 2010-2011 Work Plans included: 1.1.5, 1.8.1, 1.3.3, 2.1.5, and 2.1.2.   These Indicators 
impact healthcare systems changes for both Controlling High Blood Pressure and Controlling 
High Cholesterol, but also workplace changes and increased control of blood pressure levels for 
Controlling High Blood Pressure.  For a more detailed description of all frequently reported 
Indicators among Capacity Building Programs, see Table 4. 
Table 3 Continued 
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Table 4  Most Frequently Reported Indicators, Capacity Building Programs 
   
Capacity Building Programs 2009-2010 Work Plans 








Number of evidence-based quality improvement initiatives to 
increase practitioner compliance with Joint National Committee 
(JNC) 7 treatment guidelines 
1.8.1* 6 Proportion of individuals who have achieved blood pressure control 
1.3.3 5 
Proportion of workplaces with behavioral approaches for 
controlling high blood pressure and cardiovascular risk factors to 
employees 
1.3.6* 5 Proportion of workplaces with environmental changes to control high blood pressure 
Capacity Building Programs 2009-2010 Work Plans  







2.1.5 6 Number of quality improvements to increase practitioner adherence to current evidence-based cholesterol guidelines 
2.1.2* 4 Proportion of healthcare systems with electronic medical records appropriate for treating patients with high cholesterol 









Proportion of individuals who are aware of the risks associated 
with uncontrolled high blood pressure (both causes and 
consequences) 
1.1.3* 7 
Proportion of healthcare systems with electronic medical records 
for high blood pressure control (incl. pharmacologic and lifestyle 
modification components) 
1.1.5 7 
Number of evidence-based quality improvement initiatives to 
increase practitioner compliance with Joint National Committee 
(JNC) 7 treatment guidelines 
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1.3.3 6 
Proportion of workplaces with behavioral approaches for 
controlling high blood pressure and cardiovascular risk factors to 
employees 
1.8.1* 6 Proportion of individuals who have achieved blood pressure control 
Capacity Building Programs 2010-2011 Work Plans  







2.1.5 7 Number of quality improvements to increase practitioner adherence to current evidence-based cholesterol guidelines 
2.1.2 5 Proportion of healthcare systems with electronic medical records appropriate for treating patients with high cholesterol 
2.3.2 5 Proportion of worksites that offer behavioral approaches for employees to control high cholesterol 
2.5.5 5 Proportion of adults who are aware of their personal risk associated with high cholesterol 
*Core Indicators  
3.3 REPORTED INDICATOR UPTAKE BY PROGRAM TYPE 
As mentioned in the preface, State names were removed from this document to protect the 
confidentiality of programs.  To substitute for state names, each state received an alias.  Basic 
Implementation Programs were given the abbreviation “BI” along with a random number (1-14) 
to make each state’s identity private.   Capacity Building Programs were given the abbreviation 
“CB” along with a random number (1-28) to make each state’s identity private.    
Table 4 Continued 
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3.3.1 Basic Implementation Programs (n=14) 
An analysis of Indicator use by each Basic Implementation Program revealed that most programs 
reported more Indicators in the 2010-2011 Work Plans than in the 2009-2010 Work Plans.  The 
largest increases in reported uptake included: BI4 (2009-2010: zero Indicators, 2010-2011: 20 
Indicators), BI13 (2009-2010: zero Indicators, 2010-2011: 17 Indicators) and BI3 (2009-2010: 
zero Indicators, 2010-2011: 15 Indicators).  These programs represented three different 
geographical regions (northeast, northwest, and south).  Figure 3 provides a graphical 
representation of all 14 Basic Implementation Programs’ use of Indicators over time. 
 
Figure 3  Basic Implementation Programs' Reported Indicator Uptake: Comparison of 2009-2010 & 
2010-2011 Work Plans 
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3.3.2 Capacity Building Programs (n=28) 
An analysis of Indicator use by each Capacity Building Program revealed that many programs 
reported more Indicators in the 2010-2011 Work Plans than in the 2009-2010 Work Plans.  The 
greatest increases in reported uptake included: CB10 (2009-2010: zero Indicators, 2010-2011: 
eight Indicators) and CB26 (2009-2010: zero Indicators, 2010-2011: eight Indicators).  These 
programs represented two different geographical regions (mid-west and south).  Figure 4 
provides a graphical representation of all 28 Capacity Building Programs’ use of Indicators over 
time. 
 
Figure 4  Capacity Building Programs' Reported Indicator Uptake: Comparison of 2009-2010 & 
2010-2011 Work Plans 
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3.4 REPORTED UPTAKE OF CONTROLLING HIGH BLOOD PRESSURE 
INDICATORS BY PROGRAM TYPE 
3.4.1 Basic Implementation Programs (n=14) 
The data from Figure 3 (Basic Implementation Programs’ Reported Indicator Uptake) was split 
into two analyses, one for each priority area (Controlling High Blood Pressure and Controlling 
High Cholesterol).  Figure 5 shows the use of Controlling High Blood Pressure Indicators over 
time for all Basic Implementation Programs.  The highest increases in reported uptake again 
included: BI4 (2009-2010: zero Controlling High Blood Pressure Indicators, 2010-2011: ten 
Controlling High Blood Pressure Indicators), BI13 (2009-2010: zero Controlling High Blood 
Pressure Indicators, 2010-2011: 14 Controlling High Blood Pressure Indicators) and BI3 (2009-
2010: zero Controlling High Blood Pressure Indicators, 2010-2011: eight Controlling High 
Blood Pressure Indicators).  Each of these programs represented a different geographical region 
(northeast, northwest, and south).   See Figure 5 below for a complete summary. 
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Figure 5   Basic Implementation Programs' Reported Controlling High Blood Pressure Indicator 
Uptake: Comparison of 2009-2010 & 2010-2011 Work Plans 
3.4.2 Capacity Building Programs (n=28) 
The data from Figure 4 (Capacity Building Programs’ Reported Indicator Uptake) was split into 
two analyses, one for each priority area (Controlling High Blood Pressure and Controlling High 
Cholesterol).  Figure 6 shows the use of Controlling High Blood Pressure Indicators over time 
for all Capacity Building Programs.  The highest increases in reported uptake included: CB10 
(2009-2010: zero Controlling High Blood Pressure Indicators, 2010-2011: five Controlling High 
Blood Pressure Indicators) and CB24 (2009-2010: zero Controlling High Blood Pressure 
Indicators, 2010-2011: four Controlling High Blood Pressure Indicators).  These programs 
  32 
represented two different geographical regions (mid-west and south).  See Figure 6 below for a 
complete summary. 
 
Figure 6  Capacity Building Programs' Reported Controlling High Blood Pressure Indicator Uptake: 
Comparison of 2009-2010 & 2010-2011 Work Plans 
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3.5 REPORTED UPTAKE OF CONTROLLING HIGH CHOLESTEROL 
INDICATORS BY PROGRAM TYPE 
3.5.1 Basic Implementation Programs (n=14) 
Figure 7 shows the reported use of Controlling High Cholesterol Indicators over time for all 
Basic Implementation Programs.  The highest increases in reported uptake included: BI4 (2009-
2010: zero Controlling High Cholesterol Indicators, 2010-2011: ten Controlling High 
Cholesterol Indicators), BI5 (2009-2010: four Controlling High Cholesterol Indicators, 2010-
2011: ten Controlling High Cholesterol Indicators) and BI11 (2009-2010: one Controlling High 
Cholesterol Indicator, 2010-2011: six Controlling High Cholesterol Indicators).  These programs 
represented two different geographical regions (northeast and west).  See Figure 7 below for a 
complete summary. 
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Figure 7  Basic Implementation Programs' Reported Controlling High Cholesterol Indicator Uptake: 
Comparison of 2009-2010 & 2010-2011 Work Plans 
3.5.2 Capacity Building Programs (n=28) 
Figure 8 shows the reported use of Controlling High Cholesterol Indicators over time for all 
Capacity Building Programs.  The greatest increases in reported uptake included: CB19 (2009-
2010: zero Controlling High Cholesterol Indicators, 2010-2011: four Controlling High 
Cholesterol Indicators) and CB26 (2009-2010: zero Controlling High Cholesterol Indicators, 
2010-2011: four Controlling High Cholesterol Indicators).  These programs represented two 
different geographical regions (mid-west and south).  See Figure 8 below for a complete 
summary. 
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Figure 8  Capacity Building Programs' Reported Controlling High Cholesterol Indicator Uptake: 
Comparison of 2009-2010 & 2010-2011 Work Plans 
3.6 REPORTED UPTAKE OF CORE INDICATORS BY PRIORITY AREA 
3.6.1 All Programs (n=42) 
A subsequent analysis documented change in the uptake of Core Indicators (discussed in 2.2.1.1 
Core Indicators) from the 2009-2010 to the 2010-2011 Work Plans.  For Controlling High Blood 
Pressure, more state HDSP programs reported uptake the following Core Indicators over time: 
1.1.3 (+3), 1.2.6 (+3), 1.3.6 (+5), 1.4.2 (+3), 1.5.1 (+4), and 1.9.5 (+2).  These Indicators spanned 
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a total of six different logic model boxes, covering both short- and long-term outcomes.  For 
Controlling High Cholesterol, the following Core Indicators were reported by more state HDSP 
programs over time: 2.1.2 (+4), 2.2.6 (+1), 2.4.1 (+1), 2.6.7 (+2), 2.7.1 (+1), 2.8.1 (+1), 2.8.2 
(+1), and 2.8.5 (+8).   These Indicators spanned a total of six different logic model boxes, 
covering both short- and medium-term outcomes.  Table 5 provides a complete list of reported 
Core Indicator uptake among all programs for both priority areas. 
 
Table 5  Reported Uptake of Core Indicators, All Programs 
 













Core Indicator Description 
1.1.3 8 11 
Proportion of healthcare systems with electronic 
medical records for high blood pressure control (incl. 
pharmacologic and lifestyle modification components) 
1.2.6 3 6 
Proportion of patients who receive provider-initiated 
prescription and follow-up of therapeutic lifestyle 
modifications 
1.3.6 8 13 Proportion of workplaces with environmental changes to control high blood pressure 
1.4.2 1 4 Number of community interventions to control high blood pressure 
1.5.1 7 11 
Proportion of individuals who are aware of the risks 
associated with uncontrolled HBP (both causes and 
consequences) 
1.6.9 3 3 Proportion of individuals with high blood pressure in compliance with hypertensive medication regimen 
1.7.1 3 2 Average blood pressure levels among individuals with high blood pressure 
1.8.1 11 10 Proportion of individuals who have achieved blood pressure control 
1.8.2 1 0 Disparity in blood pressure control between general and priority populations 
1.9.5 4 6 Mortality rate due to cardiovascular disease associated with high blood pressure 
1.10.2 3 3 Disparity in cardiovascular mortality between general 
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and priority populations 
 













Core Indicator Description 
2.1.2 4 8 
Proportion of healthcare systems with electronic 
medical records appropriate for treating patients with 
high cholesterol 
2.2.6 0 1 
Proportion of patients with high cholesterol who 
receive provider-initiated recommendation and follow-
up of therapeutic lifestyle modifications 
2.3.4 7 10 Proportion of worksites with environmental supports to control high cholesterol 
2.4.1 1 2 Number of legislative policies to support therapeutic lifestyle behaviors for controlling high cholesterol 
2.5.2 2 2 Proportion of adults who have had their cholesterol checked within the previous five years 
2.6.7 1 3 Proportion of adults with high cholesterol who adhere to cholesterol-lowering medication regimens 
2.7.1 0 1 Average LDL cholesterol level among adults with high cholesterol 
2.7.2 0 0 Average HDL cholesterol level among adults with high cholesterol 
2.7.4 0 0 Average total cholesterol level among adults with high cholesterol 
2.8.1 3 4 
Proportion of adults diagnosed with high cholesterol 
who have LDL cholesterol at or below goal as defined 
by current evidence-based guidelines 
2.8.2 0 1 
Proportion of adults diagnosed with high cholesterol 
who have LDL cholesterol at or below goal as defined 
by current evidence-based guidelines 
2.8.4 3 2 
Proportion of adults diagnosed with high cholesterol 
who have total cholesterol at or below goal as defined 
by current evidence-based guidelines 
2.8.5 0 8 Disparity in high LDL cholesterol control between general and priority populations 
 
The number of programs that reported uptake of Controlling High Blood Pressure Core 
Indicators is shown below in graphical representation (see Figure 9). 
Table 5 Continued 
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Figure 9 Number of Programs Reporting Uptake of Controlling High Blood Pressure Core 
Indicators: Comparison of 2009-2010 and 2010-2011 Work Plans 
 
 
The number of programs that reported uptake of Controlling High Cholesterol Indicators is 
shown below (see Figure 10). 
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Figure 10  Number of Programs Reporting Uptake of Controlling High Cholesterol Core Indicators: 
Comparison of 2009-2010 and 2010-2011 Work Plans 
3.6.2 Basic Implementation Programs (n=14) 
A subsequent, more specific analysis of only Basic Implementation Programs documented an 
increase in reported uptake of Core Indicators from the 2009-2010 to the 2010-2011 Work Plans.  
For Controlling High Blood Pressure, more Basic Implementation Programs reported uptake of 
the following Core Indicators over time: 1.1.3 (+2), 1.2.6 (+1), 1.3.6 (+5), 1.4.2 (+4), and 1.9.5 
(+2).  For Controlling High Cholesterol, the following Core Indicators were reported by more 
Basic Implementation Programs over time: 2.1.2 (+3), 2.2.6 (+1), 2.3.4 (+4), 2.4.1 (+1), 2.6.7 
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(+1), 2.7.1 (+1), and 2.8.1 (+1).  Table 6 provides a complete list of reported Core Indicator 
uptake among Basic Implementation Programs for both priority areas. 
 
Table 6  Reported Uptake of Core Indicators, Basic Implementation Programs 
 













Core Indicator Description 
1.1.3 2 4 
Proportion of healthcare systems with electronic 
medical records for high blood pressure control (incl. 
pharmacologic and lifestyle modification components) 
1.2.6 0 1 
Proportion of patients who receive provider-initiated 
prescription and follow-up of therapeutic lifestyle 
modifications 
1.3.6 3 8 Proportion of workplaces with environmental changes to control high blood pressure 
1.4.2 0 4 Number of community interventions to control high blood pressure 
1.5.1 3 3 
Proportion of individuals who are aware of the risks 
associated with uncontrolled HBP (both causes and 
consequences) 
1.6.9 1 1 Proportion of individuals with high blood pressure in compliance with hypertensive medication regimen 
1.7.1 0 0 Average blood pressure levels among individuals with high blood pressure 
1.8.1 5 4 Proportion of individuals who have achieved blood pressure control 
1.8.2 1 0 Disparity in blood pressure control between general and priority populations 
1.9.5 0 2 Mortality rate due to cardiovascular disease associated with high blood pressure 
1.10.2 0 0 Disparity in cardiovascular mortality between general and priority populations 
 













Core Indicator Description 
2.1.2 0 3 Proportion of healthcare systems with electronic 
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medical records appropriate for treating patients with 
high cholesterol 
2.2.6 0 1 
Proportion of patients with high cholesterol who 
receive provider-initiated recommendation and follow-
up of therapeutic lifestyle modifications 
2.3.4 3 7 Proportion of worksites with environmental supports to control high cholesterol 
2.4.1 0 1 Number of legislative policies to support therapeutic lifestyle behaviors for controlling high cholesterol 
2.5.2 1 0 Proportion of adults who have had their cholesterol checked within the previous five years 
2.6.7 0 1 Proportion of adults with high cholesterol who adhere to cholesterol-lowering medication regimens 
2.7.1 0 0 Average LDL cholesterol level among adults with high cholesterol 
2.7.2 0 0 Average HDL cholesterol level among adults with high cholesterol 
2.7.4 0 0 Average total cholesterol level among adults with high cholesterol 
2.8.1 1 2 
Proportion of adults diagnosed with high cholesterol 
who have LDL cholesterol at or below goal as defined 
by current evidence-based guidelines 
2.8.2 0 0 
Proportion of adults diagnosed with high cholesterol 
who have LDL cholesterol at or below goal as defined 
by current evidence-based guidelines 
2.8.4 2 2 
Proportion of adults diagnosed with high cholesterol 
who have total cholesterol at or below goal as defined 
by current evidence-based guidelines 
2.8.5 0 0 Disparity in high LDL cholesterol control between general and priority populations 
 
3.6.3 Capacity Building Programs (n=28) 
Another more specific analysis of only Capacity Building Programs documented an increase in 
reported uptake of Core Indicators from the 2009-2010 to the 2010-2011 Work Plans.  For 
Controlling High Blood Pressure, the following Core Indicators were reported by more Capacity 
Building Programs over time: 1.1.3 (+1), 1.2.6 (+2), and 1.5.1 (+4).  For Controlling High 
Table 6 Continued 
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Cholesterol, the following Core Indicators were reported by more Capacity Building Programs 
over time: 2.1.2 (+1), 2.5.2 (+1), 2.6.7 (+1), 2.7.1 (+1), and 2.8.2 (+1).  Table 7 provides a 
complete list of reported Core Indicator uptake among Capacity Building Programs for both 
priority areas. 
 
Table 7  Reported Uptake of Core Indicators, Capacity Building Programs 
 













Core Indicator Description 
1.1.3 6 7 
Proportion of healthcare systems with electronic 
medical records for high blood pressure control (incl. 
pharmacologic and lifestyle modification components) 
1.2.6 3 5 
Proportion of patients who receive provider-initiated 
prescription and follow-up of therapeutic lifestyle 
modifications 
1.3.6 5 5 Proportion of workplaces with environmental changes to control high blood pressure 
1.4.2 1 0 Number of community interventions to control high blood pressure 
1.5.1 4 8 
Proportion of individuals who are aware of the risks 
associated with uncontrolled HBP (both causes and 
consequences) 
1.6.9 2 2 Proportion of individuals with high blood pressure in compliance with hypertensive medication regimen 
1.7.1 3 2 Average blood pressure levels among individuals with high blood pressure 
1.8.1 6 6 Proportion of individuals who have achieved blood pressure control 
1.8.2 0 0 Disparity in blood pressure control between general and priority populations 
1.9.5 4 4 Mortality rate due to cardiovascular disease associated with high blood pressure 
1.10.2 3 3 Disparity in cardiovascular mortality between general and priority populations 
 
Controlling High Cholesterol Core Indicators 
Core Number of Number of Core Indicator Description 









2.1.2 4 5 
Proportion of healthcare systems with electronic 
medical records appropriate for treating patients with 
high cholesterol 
2.2.6 0 0 
Proportion of patients with high cholesterol who 
receive provider-initiated recommendation and follow-
up of therapeutic lifestyle modifications 
2.3.4 4 3 Proportion of worksites with environmental supports to control high cholesterol 
2.4.1 1 1 Number of legislative policies to support therapeutic lifestyle behaviors for controlling high cholesterol 
2.5.2 1 2 Proportion of adults who have had their cholesterol checked within the previous five years 
2.6.7 1 2 Proportion of adults with high cholesterol who adhere to cholesterol-lowering medication regimens 
2.7.1 0 1 Average LDL cholesterol level among adults with high cholesterol 
2.7.2 0 0 Average HDL cholesterol level among adults with high cholesterol 
2.7.4 0 0 Average total cholesterol level among adults with high cholesterol 
2.8.1 2 2 
Proportion of adults diagnosed with high cholesterol 
who have LDL cholesterol at or below goal as defined 
by current evidence-based guidelines 
2.8.2 0 1 
Proportion of adults diagnosed with high cholesterol 
who have LDL cholesterol at or below goal as defined 
by current evidence-based guidelines 
2.8.4 1 0 
Proportion of adults diagnosed with high cholesterol 
who have total cholesterol at or below goal as defined 
by current evidence-based guidelines 
2.8.5 0 0 Disparity in high LDL cholesterol control between general and priority populations 
 
Table 7 Continued 
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3.7 VARIATION OF REPORTED INDICATOR UPTAKE 
3.7.1 All Programs (n=42) 
State HDSP programs demonstrated an increase in the variety of Indicators reported in program 
planning activities.  Across all programs over time, the number of different Indicators reported in 
Work Plans increased from 65 to 80 out of a possible 120 Indicators.  This increase of 15 
Indicators was made up of state HDSP programs reporting uptake of a total of two additional 
Controlling High Blood Pressure Indicators and 13 additional Controlling High Cholesterol 
Indicators from the 2009-2010 to the 2010-2011 Work Plans (see Table 8). 
3.7.2 Basic Implementation Programs (n=14) 
Basic Implementation programs showed an increase in the variety of Indicators reported in 
program planning activities.  Across all Basic Implementation Programs, the number of different 
Indicators reported in Work Plans increased from 40 to 58 out of a possible 120 Indicators.  This 
increase of 18 Indicators was made up of Basic Implementation Programs reporting uptake of a 
total of four additional Controlling High Blood Pressure Indicators and 14 additional Controlling 
High Cholesterol Indicators from the 2009-2010 to the 2010-2011 Work Plans (see Table 8). 
3.7.3 Capacity Building Programs (n=28) 
Capacity Building programs also demonstrated an increase in the variety of Indicators reported 
in program planning activities.  Across all Capacity Building Programs, the number of different 
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Indicators reported in Work Plans increased from 56 to 67 out of a possible 120 Indicators.  This 
increase of 11 Indicators was made up of Capacity Building Programs reporting uptake of a total 
of five additional Controlling High Blood Pressure Indicators and six additional Controlling 
High Cholesterol Indicators from the 2009-2010 to the 2010-2011 Work Plans (see Table 8). 
Table 8  Variation of Reported Indicator Uptake by Program Type 
    
All Programs 2009-2010 Work Plan 
2010-2011 
Work Plan Difference 
Number of Different Indicators Reported 65 out of 120 (54%) 
80 out of 
120 (67%) +15 
Number of Different Controlling High Blood Pressure 
Indicators Reported 
43 out of 
63 (68%) 
45 out of 
63 (71%) +2 
Number of Different Controlling High Cholesterol 
Indicators Reported 
22 out of 
57 (39%) 
35 out of 
57 (61%) +13 
 
Basic Implementation Programs 2009-2010 Work Plan 
2010-2011 
Work Plan Difference 
Number of Different Indicators Reported 40 out of 120 (33%) 
58 out of 
120 (48%) +18 
Number of Different Controlling High Blood Pressure 
Indicators Reported 
27 out of 
63 (43%) 
31 out of 
63 (49%) +4 
Number of Different Controlling High Cholesterol 
Indicators Reported 
13 out of 
57 (23%) 
27 out of 
57 (47%) +14 
 
Capacity Building Programs 2009-2010 Work Plan 
2010-2011 
Work Plan Difference 
Number of Different Indicators Reported 56 out of 120 (47%) 
67 out of 
120 (56%) +11 
Number of Different Controlling High Blood Pressure 
Indicators Reported 
36 out of 
63 (57%) 
41 out of 
63 (65%) +5 
Number of Different Controlling High Cholesterol 
Indicators Reported 
20 out of 
57 (35%) 
26 out of 
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4.0  DISCUSSION 
4.1 IN COMPARISON: BASIC IMPLEMENTATION AND CAPACITY BUILDING 
PROGRAMS 
On Average, Basic Implementation Programs Report More Indicators per Work Plan.  
Both Basic Implementation and Capacity Building Programs showed an increase in the average 
number of Indicators reported in Work Plans over time.  However, Basic Implementation 
Programs showed a substantially larger increase in the average number of Indicators reported per 
program (see Table 9). This observation was likely due to the nature of Basic Implementation 
Programs in comparison to Capacity Building Programs; Basic Implementation Programs are 
funded for the purpose of implementing initiatives and, therefore, have the ability to impact more 
Indicators. 








Average Increase in Number of Reported Indicators per 
Program from 2009-2011 +5.1 +0.9 
Average Increase in Number of Reported Controlling High 
Blood Pressure Indicators per Program from 2009-2011 +2.6 +0.3 
Average Increase in Number of Reported Controlling High 
Cholesterol Indicators per Program from 2009-2011 +2.5 +0.6 
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Over Time, State HDSP Programs Showed an Increase in Reporting Use of Indicators.  
Table 1 emphasizes that the average number of Indicators reported among each funding-type 
(Basic Implementation and Capacity Building) were affected by the programs that did not report 
any Indicators in the 2009-2010 and/or 2010-2011 Work Plans.  For that reason, Table 1 includes 
an “only non-zero analysis” for each funding type to show the difference in the frequency of 
reported Indicator use among programs that did and did not report Indicators in their Work Plans.  
However, the “non-zero analyses” did not show a greater increase in average number of 
Indicators reported over time for Capacity Building Programs, suggesting that (a) the Capacity 
Building Programs that reported Indicators in 2009-2010 have not increased their average 
number of Indicators per Work Plan over time, and (b) there are fewer Capacity Building 
Programs neglecting to report Indicators in Work Plans over time.  In other words, as time 
progresses, more Capacity Building Programs are linking their intervention activities to the 
DHDSP’s logic models for Controlling High Blood Pressure and Controlling High Cholesterol 
(via Indicators) and less programs are neglecting Indicators all together. 
 
Indicator 1.1.5.  Based on the total frequency of reported use in the 2009-2010 and 2010-2011 
Work Plans, Controlling High Blood Pressure Indicator 1.1.5 (Number of evidence-based quality 
improvement initiatives to increase practitioner compliance with JNC 7 treatment guidelines) 
was the most commonly reported Indicator over time for both Basic Implementation and 
Capacity Building Programs.  This Indicator was reported 25 times across all 2009-2010 and 
2010-2011 Work Plans, more than any other Indicator. 
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Variety Is Increasing Over Time.  Both Capacity Building and Basic Implementation Programs 
increased the variety of Indicators reported over time (see Table 8).  Although there are only 14 
Basic Implementation Programs, compared with 28 Capacity Building Programs, Basic 
Implementation Programs showed a larger increase in variation of reported Indicator usage over 
time.   In addition, Basic Implementation Programs increased the average number of Controlling 
High Cholesterol Indicators reported per program substantially over time (see Table 8).  This, 
again, is likely due to the nature and funding capabilities of Basic Implementation Programs to 
address more Indicators with their interventions. 
 
Overall Unused Indicators.  Many Indicators were not reported by state HDSP programs.  This 
was likely due to the inability of programs to address all of the Indicators provided.  Essentially, 
the “menu” of 120 Indicators was meant to serve as a guide for state HDSP programs to use 
when planning, implementing, and evaluating interventions.  In reality, the DHDSP recognizes 
that not all of the Indicators can be addressed; however, it is useful to know which Indicators are 
not used so as to foster better programming and technical assistance.  Overall, 36 Indicators were 
not reported by Capacity Building or Basic Implementation Programs in any Work Plan from 
2009 to 2011.  Among only Basic Implementation Programs, 54 Indicators were not reported in 
any Work Plans from 2009 to 2011.  Among only Capacity Building Programs, 48 Indicators 
were not reported in any Work Plans from 2009-2011. Appendix D provides a complete list of 
all unused Indicators.   
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4.2 LIMITATIONS 
4.2.1 Disproportionate Advantage 
Indicators for Controlling High Blood Pressure were made available to programs before the 
2009-2010 Work Plans were written, while Controlling High Cholesterol were not available to 
programs until after the 2009-2010 Work Plans were written. State HDSP programs were 
provided with a set of Indicators for Controlling High Blood Pressure in 2008.  That list of 
Indicators also denoted the specific Core Indicators for Controlling High Blood Pressure.  Since 
the list of Core Indicators was released by the CDC, the overseeing organization, there existed 
potential for selection bias when state HDSP program were linking initiatives to Indicators.  
State HDSP programs were aware of the menu of Controlling High Blood Pressure Core 
Indicators and may have been more inclined to link activities and objectives to them because of 
that awareness and a desire to “please the CDC.”  However, the Indicators for Controlling High 
Cholesterol were not released to the state HDSP programs until November 2009, after the 2009-
2010 Work Plans were submitted, and the list of Core Indicators for Controlling High 
Cholesterol was never released.  Unlike the Controlling High Blood Pressure Indicators, state 
HDSP programs were not given a list of the Core Indicators for Controlling High Cholesterol to 
avoid the possibility for programs deliberately choosing them simply to be looked upon 
favorably (the same bias that was a concern with the release of the Core Indicators for 
Controlling High Blood Pressure).  This, essentially, was likely to have had a negative effect on 
the reported uptake of Controlling High Cholesterol Indicators in the 2009-2010 Work Plans 
because programs that had already submitted Work Plans would have had to go back into the 
HDSP MIS, re-submit all of their interventions, and report on the Controlling High Cholesterol 
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Indicators.  Furthermore, the lack of a Core Indicator list for Controlling High Cholesterol likely 
had a negative effect on the reporting of Controlling High Cholesterol Core Indicators for both 
the 2009-2010 Work Plans and the 2010-2011 Work Plans.  In essence, the dates of release of 
Indicators and the denotation of Core Indicators are important factors that were likely to affect 
the reporting of Indicators among programs. 
4.2.2 Unrepresented States and Varied Opportunities 
Some programs reported more Indicators in Work Plans compared with others.  Twelve 
programs neglected to report any Controlling High Blood Pressure or Controlling High 
Cholesterol Indicators in the 2009-2010 Work Plans.  These programs represented all geographic 
regions of the United States.  Five programs neglected to report any Controlling High Blood 
Pressure or Controlling High Cholesterol Indicators in the 2010-2011 Work Plans.  These 
programs represented most regions of the United States (south, west, and northeast).  However, 
neglecting to report Indicators in bi-annual Work Plans is not sufficient evidence to make 
assumptions about the quality of a program. 
When a state HDSP program does not explicitly link an Indicator to an intervention 
activity, it does not necessarily mean that:  (a) their activities will not have an effect on an 
Indicator or Indicators, or that (b) the state HDSP program is performing poorly.  In fact, the 
opportunities to address CVD vary from state to state and will change over time.  The varied 
amounts of Indicators created by the CDC exemplify the following point: different state HDSP 
programs may need to address different Indicators because particular Indicators are more 
relevant to their interventions, partnerships, available resources, etc.  For example, a state HDSP 
might suspect that an initiative will impact multiple Indicators but only has the capacity to 
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measure one of them, therefore, they choose to only link the activity to one Indicator (even 
though it will likely impact several).   
State HDSP programs are encouraged to select criteria that are most suited to the context 
of their programs and most important to the key stakeholders involved.  Since different states 
received different amounts of funding to support their state HDSP program activities (Basic 
Implementation programs receive more funding than Capacity Building programs), the number 
of activities feasible for each program to fund may be limited.  In other words, state HDSP 
programs that receive a portion of the amount of funding that another state HDSP program 
receives will have a limited capacity for interventions due to funding or capacity limitations.  
This would directly affect the ability of a program to impact an Indicator, thus, affecting the 
reporting of Indicator uptake in Work Plans. 
4.2.3 Cultural Competence 
While the results of this report may support the guidance of state HDSP programs and help to 
initiate a common understanding of what Indicators are impacted nationwide, state HDSP 
programs should not be encouraged to impact one Indicator over another in order to “match” the 
perceived successes of another state HDSP program. The opposite is true as well; state HDSP 
program should not be discouraged from impacting an Indicator that another state HDSP showed 
little success in impacting.  As mentioned above, one state HDSP programs activities may not be 
practical for another to adopt.  This emphasizes the importance of culturally relevant approaches 
to state HDSP program activities.  However, for state HDSP programs that share a vision for 
impacting an Indicator, this report can facilitate and enhance a Community of Practice by 
encouraging state HDSP programs to share strategies and leverage potential resources. 
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4.3 FUTURE DIRECTIONS 
4.3.1 Improve Reporting in the HSDSP MIS 
The quality of the data gathered for these analyses are only as valid as the quality and accuracy 
of the information put into the HDSP MIS.  In reality, there is no way to validate the data entered 
into the HDSP MIS; that is, there is no way of knowing for certain that a state is truly impacting 
the Indicators that are reported in their Work Plans (at least in no immediate sense).  State HDSP 
programs use their discretion when deciding what Indicators are impacted by their activities and 
may or may not go through a complete process of using the Indicators as a true measure of 
performance.  Since, in that sense, the reporting methods are a subjective decision-making 
process, there remains the possibility that: (a) some activities impact other Indicators that are not 
included (due to capacity limitations) – especially activities that can impact Indicators for both 
Controlling High Blood Pressure and Controlling High Cholesterol simultaneously, and (b) the 
activities do not truly impact the Indicator mentioned and it was chosen simply because it was 
the “closest match” for the program to choose.   
Furthermore, “chosen” Indicators frequently change when a state HDSP program 
receives technical assistance from DHDSP personnel.  DHDSP personnel often assist with the re-
direction and re-focusing of state activities during conference calls and site visits.  Since the state 
HDSP programs are required to submit a Work Plan bi-annually, some of the information 
entered into the HDSP MIS may be out of date, which can vary depending on the time of year 
when accessing the data.  Nonetheless, the HDSP MIS Work Plan summaries remain the best 
source for gathering information about states HDSP programs’ reported use of Indicators when 
implementing a HDSP intervention.  
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4.3.2 Maintenance 
The information presented in this report can be used to for various purposes: (a) to provide 
guidance to state HDSP programs, (b) to visualize the trends and patterns in the reported use of 
Indicators for Controlling High Blood Pressure and Controlling High Cholesterol among state 
HDSP programs, (c) to encourage accountability, and (d) to share the strengths and/or areas for 
improvement with state HDSP programs to foster better programming.  Regular analysis of 
Work Plans should be conducted to intermittently acknowledge trends and patterns in the 
reported use of Controlling High Blood Pressure and High Cholesterol Indicators in state HDSP 
program planning activities.   
4.3.3 Percentage of Objectives with Indicators 
A future analysis of the percentage of state HDSP program objectives reportedly linked to 
Indicators would provide information on the effectiveness of Indicator use in framing a state 
HDSP program’s goals.  In other words, by understanding the effect that Indicator use has on a 
program’s ability to measure success, the goals and objectives of a state HDSP program can be 
more easily achieved.  State HDSP programs can, and should, use Indicators to provide a clearer 
understanding of what to measure in order to document improvements. 
4.3.4 Reach and Impact Analysis 
State HDSP programs should be strongly encouraged to impact Indicators with their activities 
and objectives listed in each Work Plan in order to establish a firm understanding of state 
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planning activities and goals.  A more in-depth analysis of the estimated and actual reach and 
impact of interventions founded upon evidence-based Indicators would yield valuable 
information. This would help to answer a much larger question, “Does the appropriate use of 
Indicators as a performance measure improve documentation of the actual reach and impact for 
state HDSP programs?”  This would also produce a better understanding of the link between the 
use of Indicators in state HDSP activities and the actual outcomes that are measured.  Findings 
from that analysis would enhance technical assistance, improve program planning and 
development, and support the use of indicators as performance measures for any public health 








  55 
APPENDIX A 
COMPREHENSIVE LIST OF CONTROLLING HIGH BLOOD PRESSURE AND 
CONTROLLING HIGH CHOLESTEROL INDICATORS 
 
Controlling High Blood Pressure Indicators 
Healthcare Systems Indicators 
1.1.1 
Proportion of healthcare systems with policies to encourage multi-disciplinary team approach to enhance high blood 
pressure control 
1.1.2 Prevalence of specialized chronic care clinics with a focus on high blood pressure control 
1.1.3* 
Proportion of healthcare systems with electronic medical records for high blood pressure control (incl. pharmacologic and 
lifestyle modification components) 
1.1.4 Proportion of healthcare systems with computer-based clinical decision support systems 
1.1.5 
Number of evidence-based quality improvement initiatives to increase practitioner compliance with joint national committee 
(JNC) 7 treatment guidelines 
1.1.6 
Proportion of healthcare systems with evidence-based health education programs for high blood pressure control and 
treatment 
1.1.7 Proportion of healthcare systems with policies to follow up with patients screened with high blood pressure 
1.1.8 
Proportion of healthcare systems with policies to increase patient adherence with high blood pressure treatment (incl. 
Pharmacologic and lifestyle modification components) 
1.1.9 Proportion of healthcare systems with policies to encourage patient self-management of chronic high blood pressure 
Healthcare Providers Indicators 
1.2.1 Proportion of providers who measure blood pressure according to JNC guidelines 
1.2.2 Proportion of providers who classify blood pressure according to current evidence-based high blood pressure guidelines 
1.2.3 Proportion of providers who document major cardiovascular risk factors noted in JNC guidelines 
1.2.4 Proportion of providers who follow JNC pharmacologic guidelines prior to initiating therapy 
1.2.5 Proportion of providers who follow JNC pharmacologic therapies algorithm for treatment of high blood pressure 
1.2.6* Proportion of patients who receive provider-initiated prescription and follow-up of therapeutic lifestyle modifications 
1.2.7 
Proportion of patients with uncontrolled high blood pressure who have documented provider initiated changes in high blood 
pressure pharmaceutical intervention (antihypertensive drug treatment) 
Worksite Indicators 
1.3.1 Proportion of worksites with employer payment for services to control high blood pressure and cardiovascular risk factors 
1.3.2 
Proportion of workplaces with incentive based worksite health promotion programs specific to control of high blood 
pressure 
1.3.3 
Proportion of workplaces with behavioral approaches for controlling high blood pressure and cardiovascular risk factors to 
employees 
1.3.4 Proportion of workplaces providing health risk assessments with blood pressure screening for early detection or monitoring 
1.3.5 Proportion of workplaces with on-site clinical health services or physician referrals to control high blood pressure 
1.3.6* Proportion of workplaces with environmental changes to control high blood pressure 
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Community Indicators 
1.4.1 Number of legislative policies to support therapeutic lifestyle behaviors for blood pressure control 
1.4.2* Number of community interventions to control high blood pressure 
1.4.3 Prevalence of health education activities to control high blood pressure 
1.4.4 Number of community environmental changes to control high blood pressure 
1.4.5 Proportion of community-based organizations that are linked to the health care and public health systems 
Individual Indicators 
1.5.1* 
Proportion of individuals who are aware of the risks associated with uncontrolled high blood pressure (both causes and 
consequences) 
1.5.2 Proportion of individuals who know what therapeutic lifestyle changes are associated with blood pressure control 
1.5.3 Disparity between general and priority populations regarding awareness of high blood pressure control risk factors 
1.5.4 Proportion of individuals with an identified high blood pressure self management goal to enhance self-efficacy 
1.5.5 Proportion of individuals who have participated in at least one high blood pressure education program 
1.5.6 
Proportion of individuals who have visited a healthcare provider according to clinical guidelines for treatment of high blood 
pressure 
1.5.7 Number of patients with missed follow-up provider appointments for treatment of high blood pressure 
1.5.8 Proportion of individuals satisfied with healthcare services 
1.5.9 
Average annual out-of-pocket patient costs for prescription drugs attributable to the treatment of high blood pressure (per 
person with high blood pressure) 
1.5.10 
Average annual out-of-pocket patient costs associated with therapeutic lifestyle modification for the treatment of high blood 
pressure (per person with high blood pressure) 
Risk Factors Indicators 
1.6.1 Disparity in high blood pressure risk factors between general and priority populations 
1.6.2 Proportion of individuals reporting lifestyle behavior change to control high blood pressure 
1.6.3 Smoking prevalence 
1.6.4 Proportion of smokers who have made a quit attempt using proven cessation methods 
1.6.5 Prevalence of obesity 
1.6.6 Proportion of adults who participate regularly in physical activity 
1.6.7 Proportion of individuals adopting the dietary approaches to stop hypertension (dash) eating plan 
1.6.8 Proportion of individuals reporting elevated levels of stress 
1.6.9* Proportion of individuals with high blood pressure in compliance with hypertensive medication regimen 
1.6.10 Disparity between general and priority populations  compliance with high blood pressure control regimens 
Blood Pressure Reduction Indicators 
1.7.1* Average blood pressure levels among individuals with high blood pressure 
1.7.2 Average frequency blood pressure levels measured among individuals with high blood pressure 
1.7.3 
Disparity in blood pressure levels between general and priority populations that have been diagnosed with high blood 
pressure 
Increased Control Indicators 
1.8.1* Proportion of individuals who have achieved blood pressure control 
1.8.2* Disparity in blood pressure control between general and priority populations 
Lower Morbidity/Mortality Indicators 
1.9.1 Proportion of individuals with elevated cardiovascular risk 
Appendix A Continued 
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1.9.2 
Average level of quality of life 
1.9.3 Proportion of individuals requiring hospitalization/emergency care associated with high blood pressure associated outcomes 
1.9.4 Prevalence of nonfatal cardiovascular events associated with high blood pressure 
1.9.5* Mortality rate due to cardiovascular disease associated with high blood pressure 
Disparities Indicators 
1.10.1 Disparity in cardiovascular morbidity associated with high blood pressure between general and priority populations 
1.10.2* Disparity  in cardiovascular mortality between general and priority populations 
Reduced Costs Indicators 
1.11.1 
Average annual employer costs attributable to high blood pressure and related health outcomes (per person with high blood 
pressure) 
1.11.2 
Average annual outpatient costs attributable to high blood pressure and related health outcomes (per person with high blood 
pressure) 
1.11.3 
Average annual inpatient costs attributable to high blood pressure and related health outcomes (per person with high blood 
pressure) 
1.11.4 
Average annual costs of emergency room services attributable to high blood pressure and related health outcomes (per 
person with high blood pressure) 
  
Controlling High Cholesterol Indicators 
Healthcare Systems Indicators 
2.1.1 Proportion of healthcare systems with policies that identify LDL cholesterol as the primary target of lipid-lowering therapy 
2.1.2* Proportion of healthcare systems with electronic medical records appropriate for treating patients with high cholesterol 
2.1.3 Prevalence of specialized chronic care clinics with a focus on high cholesterol 
2.1.4 
Proportion of healthcare systems with treatment algorithms that incorporate recommendations of current evidence-based 
cholesterol guidelines 
2.1.5 Number of quality improvements to increase practitioner adherence to current evidence-based cholesterol guidelines 
2.1.6 Proportion of healthcare systems with policies to follow up with patients tested for high cholesterol 
2.1.7 
Proportion of healthcare systems with policies to increase patient adherence to high cholesterol treatment (incl. lifestyle 
modification and pharmacologic components) 
Healthcare Providers Indicators 
2.2.1 Proportion of providers who order blood cholesterol tests according to current evidence-based guidelines 
2.2.2 Proportion of providers who classify LDL, HDL, and total cholesterol according to current evidence-based guidelines 
2.2.3 
Proportion of providers who document major cardiovascular risk factors noted in current evidence-based cholesterol 
guidelines 
2.2.4 
Proportion of providers who increase monitoring and shifts in medication for patients unable to achieve cholesterol 
treatment goals 
2.2.5 
Proportion of providers who follow current evidence-based guideline algorithms for pharmacologic therapies to treat high 
cholesterol 
2.2.6* 
Proportion of patients with high cholesterol who receive provider-initiated recommendation and follow-up of therapeutic 
lifestyle modifications 
2.2.7 Proportion of providers who counsel patients with high cholesterol on how to take prescribed medicines 
2.2.8 Proportion of providers who work with patients to identify cholesterol self management goals 
Worksite Indicators 
2.3.1 Proportion of worksites with employer payment for services to control high cholesterol 
2.3.2 Proportion of worksites that offer behavioral approaches for employees to control high cholesterol 
2.3.3 Proportion of worksites that provide health risk assessments that include high cholesterol monitoring 
2.3.4* Proportion of worksites with environmental supports to control high cholesterol 
Community Indicators 
2.4.1* Number of legislative policies to support therapeutic lifestyle behaviors for controlling high cholesterol 
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2.4.2 
Number of community interventions to control high cholesterol 
2.4.3 Number of community environmental supports to control high cholesterol 
2.4.4 
Proportion of community-based organizations that are linked to healthcare and public health systems to support control of 
high cholesterol 
Individual Indicators 
2.5.1 Proportion of adults who have had their cholesterol checked within the previous five years 
2.5.2* Proportion of adults who have had their cholesterol checked within the previous five years 
2.5.3 Disparity in knowledge of the risks of high cholesterol between general and priority populations 
2.5.4 Proportion of adults who know which therapeutic lifestyle behavior changes are associated with controlling high cholesterol 
2.5.5 Proportion of adults who are aware of their personal risk associated with high cholesterol 
2.5.6 Annual out-of-pocket patient coasts for prescription medication for the treatment of high cholesterol 
2.5.7 Average annual out-of-pocket costs associated with therapeutic lifestyle modification for the treatment of high cholesterol 
Risk Factors Indicators 
2.6.1 Proportion of adults who follow a recommended diet to reduce their high cholesterol 
2.6.2 Proportion of adults with high cholesterol who participate regularly in physical activity 
2.6.3 Prevalence of obesity among adults with high cholesterol 
2.6.4 Smoking prevalence among adults with high cholesterol 
2.6.5 Proportion of smokers with high cholesterol who have made a quit attempt using proven cessation methods 
2.6.6 Disparity in risk factors for high cholesterol between general and priority populations 
2.6.7* Proportion of adults with high cholesterol who adhere to cholesterol-lowering medication regimens 
2.6.8 Disparity in adherence to cholesterol-lowering medication regimens between general and priority populations 
High Cholesterol Reduction Indicators 
2.7.1* Average LDL cholesterol level among adults with high cholesterol 
2.7.2* Average HDL cholesterol level among adults with high cholesterol 
2.7.3 Average triglyceride level among adults with high cholesterol 
2.7.4* Average total cholesterol level among adults with high cholesterol 
Increased Control Indicators 
2.8.1* 
Proportion of adults diagnosed with high cholesterol who have LDL cholesterol at or below goal as defined by current 
evidence-based guidelines 
2.8.2* 
Proportion of adults diagnosed with high cholesterol who have LDL cholesterol at or below goal as defined by current 
evidence-based guidelines 
2.8.3 
Proportion of adults with high cholesterol who have non-HDL cholesterol at or below goal as defined by current evidence-
based guidelines 
2.8.4* 
Proportion of adults diagnosed with high cholesterol who have total cholesterol at or below goal as defined by current 
evidence-based guidelines 
2.8.5* Disparity in high LDL cholesterol control between general and priority populations 
Reduced Morbidity/Mortality Indicators 
2.9.1 Proportion of adults with high cholesterol who have an elevated 10-year cardiovascular risk 
2.9.2 Proportion of adults with high cholesterol who have poor quality of life 
2.9.3 Prevalence of nonfatal cardiovascular events associated with high cholesterol 
2.9.4 Death rate due to cardiovascular disease associated with high cholesterol 
Disparities Indicators 
Appendix A Continued 
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2.10.1 
Disparity in cardiovascular morbidity associated with high cholesterol between general and priority populations 
2.10.2 Disparity in cardiovascular mortality associated with high cholesterol between general and priority populations 
Reduced Costs Indicators 
2.11.1 Average annual employer costs attributable to high cholesterol and related health outcomes 
2.11.2 Average annual outpatient costs attributable to high cholesterol and related health outcomes 
2.11.3 Average annual inpatient costs attributable to high cholesterol and related health outcomes 
2.11.4 Average annual emergency department costs attributable to high cholesterol and related health outcomes 
*Core Indicators 
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APPENDIX B  
CONTROLLING HIGH BLOOD PRESSURE LOGIC MODEL 
 
NOTES: Indicators correspond to the logic model in an “a.b.c” format where: “a” indicates the priority area (High Blood Pressure Control = 1, 
High Cholesterol Control = 2); “b” indicates which Box in the appropriate logic model the indicators corresponds to (i.e. Healthcare System 
Changes = 1, Provider Changes = 2, etc.); and “c” enumerates and identifies the specific indicators itself (i.e. 1.1.1 = The proportion of 
healthcare systems with policies to encourage a multi-disciplinary team approach to enhance high blood pressure control: Controlling High 
Blood Pressure Indicator corresponding to Box 1, Health Care System Changes) 4, 5.  (Data as of 8/4/2010). 
SOURCE: Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention. Controlling High Blood Pressure 
Logic Model. Atlanta, GA: Centers for Disease Control and Prevention. 2008. 
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APPENDIX C 
CONTROLLING HIGH CHOLESTEROL LOGIC MODEL 
 
NOTES: Indicators correspond to the logic model in an “a.b.c” format where: “a” indicates the priority area (High Blood Pressure Control = 1, 
High Cholesterol Control = 2); “b” indicates which Box in the appropriate logic model the indicators corresponds to (i.e. Healthcare System 
Changes = 1, Provider Changes = 2, etc.); and “c” enumerates and identifies the specific indicators itself (i.e. 2.1.1 = The proportion of 
healthcare systems with policies that identify LDL cholesterol as the primary target of lipid-lowering therapy: Controlling High Cholesterol 
Indicator corresponding to Box 1, Health Care System Changes) 4, 5.  (Data as of 8/4/2010). 
SOURCE: Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention. Controlling High Cholesterol Logic 
Model. Atlanta, GA: Centers for Disease Control and Prevention. 2008. 
  62 
APPENDIX D  
UNUSED INDICATORS 
All Programs Unused Indicators (Core Indicators are bolded): 
 
1. 1.2.4 (Proportion of providers who follow JNC pharmacologic guidelines prior to 
initiating therapy) 
2. 1.5.2 (Proportion of individuals who know what therapeutic lifestyle changes are 
associated with blood pressure control) 
3. 1.5.7 (Number of patients with missed follow-up provider appointments for treatment 
of high blood pressure) 
4. 1.5.8 (Proportion of individuals satisfied with healthcare services) 
5. 1.5.9 (Average annual out-of-pocket patient costs for prescription drugs attributable 
to the treatment of high blood pressure [per person with high blood pressure]) 
6. 1.5.10 (Average annual out-of-pocket patient costs associated with therapeutic 
lifestyle modification for the treatment of high blood pressure [per person with high 
blood pressure]) 
7. 1.6.5 (Prevalence of obesity) 
8. 1.6.8 (Proportion of individuals reporting elevated levels of stress) 
9. 1.6.10 (Disparity between general and priority populations  compliance with high 
blood pressure control regimens) 
10. 1.7.3 (Disparity in blood pressure levels between general and priority populations 
that have been diagnosed with high blood pressure) 
11. 1.9.2 (Average level of quality of life) 
12. 1.9.3 (Proportion of individuals requiring hospitalization/emergency care associated 
with high blood pressure associated outcomes) 
13. 1.9.4 (Prevalence of nonfatal cardiovascular events associated with high blood 
pressure) 
14. 1.11.2 (Average annual outpatient costs attributable to high blood pressure and 
related health outcomes [per person with high blood pressure]) 
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15. 1.11.3 (Average annual inpatient costs attributable to high blood pressure and 
related health outcomes [per person with high blood pressure]) 
16. 1.11.4 (Average annual costs of emergency room services attributable to high blood 
pressure and related health outcomes [per person with high blood pressure]) 
17. 2.1.1 (Proportion of healthcare systems with policies that identify LDL cholesterol as 
the primary target of lipid-lowering therapy) 
18. 2.1.4 (Proportion of healthcare systems with treatment algorithms that incorporate 
recommendations of current evidence-based cholesterol guidelines) 
19. 2.2.7 (Proportion of providers who counsel patients with high cholesterol on how to 
take prescribed medicines) 
20. 2.3.1 (Proportion of worksites with employer payment for services to control high 
cholesterol) 
21. 2.5.6 (Annual out-of-pocket patient coasts for prescription medication for the 
treatment of high cholesterol) 
22. 2.5.7 (Average annual out-of-pocket costs associated with therapeutic lifestyle 
modification for the treatment of high cholesterol) 
23. 2.6.4 (Smoking prevalence among adults with high cholesterol) 
24. 2.6.8 (Disparity in adherence to cholesterol-lowering medication regimens between 
general and priority populations) 
25. 2.7.2 (Average HDL cholesterol level among adults with high cholesterol) 
26. 2.7.3 (Average triglyceride level among adults with high cholesterol) 
27. 2.7.4 (Average total cholesterol level among adults with high cholesterol) 
28. 2.8.5 (Disparity in high LDL cholesterol control between general and priority 
populations) 
29. 2.9.2 (Proportion of adults with high cholesterol who have poor quality of life) 
30. 2.9.3 (Prevalence of nonfatal cardiovascular events associated with high cholesterol) 
31. 2.10.1 (Disparity in cardiovascular morbidity associated with high cholesterol 
between general and priority populations) 
32. 2.10.2 (Disparity in cardiovascular mortality associated with high cholesterol 
between general and priority populations) 
33. 2.11.1 (Average annual employer costs attributable to high cholesterol and related 
health outcomes) 
34. 2.11.2 (Average annual outpatient costs attributable to high cholesterol and related 
health outcomes) 
35. 2.11.3 (Average annual inpatient costs attributable to high cholesterol and related 
health outcomes) 
36. 2.11.4 (Average annual emergency department costs attributable to high cholesterol 
and related health outcomes) 
 
Capacity Building Program Unused Indicators (Core Indicators are bolded): 
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1. 1.1.2 (Prevalence of specialized chronic care clinics with a focus on high blood 
pressure control) 
2. 1.2.4 (Proportion of providers who follow JNC pharmacologic guidelines prior to 
initiating therapy) 
3. 1.5.2 (Proportion of individuals who know what therapeutic lifestyle changes are 
associated with blood pressure control) 
4. 1.5.7 (Number of patients with missed follow-up provider appointments for treatment 
of high blood pressure) 
5. 1.5.8 (Proportion of individuals satisfied with healthcare services) 
6. 1.5.9 (Average annual out-of-pocket patient costs for prescription drugs attributable 
to the treatment of high blood pressure [per person with high blood pressure]) 
7. 1.5.10 (Average annual out-of-pocket patient costs associated with therapeutic 
lifestyle modification for the treatment of high blood pressure [per person with high 
blood pressure]) 
8. 1.6.3 (Smoking prevalence) 
9. 1.6.5 (Prevalence of obesity) 
10. 1.6.6 (Proportion of adults who participate regularly in physical activity) 
11. 1.6.8 (Proportion of individuals reporting elevated levels of stress) 
12. 1.6.10 (Disparity between general and priority populations  compliance with high 
blood pressure control regimens) 
13. 1.7.3 (Disparity in blood pressure levels between general and priority populations 
that have been diagnosed with high blood pressure) 
14. 1.8.2 (Disparity in blood pressure control between general and priority populations) 
15. 1.9.2 (Average level of quality of life) 
16. 1.9.3 (Proportion of individuals requiring hospitalization/emergency care associated 
with high blood pressure associated outcomes) 
17. 1.9.4 (Prevalence of nonfatal cardiovascular events associated with high blood 
pressure) 
18. 1.11.1 (Average annual employer costs attributable to high blood pressure and 
related health outcomes [per person with high blood pressure]) 
19. 1.11.2 (Average annual outpatient costs attributable to high blood pressure and 
related health outcomes [per person with high blood pressure]) 
20. 1.11.3 (Average annual inpatient costs attributable to high blood pressure and 
related health outcomes [per person with high blood pressure]) 
21. 1.11.4 (Average annual costs of emergency room services attributable to high blood 
pressure and related health outcomes [per person with high blood pressure]) 
22. 2.1.1 (Proportion of healthcare systems with policies that identify LDL cholesterol as 
the primary target of lipid-lowering therapy) 
23. 2.1.4 (Proportion of healthcare systems with treatment algorithms that incorporate 
recommendations of current evidence-based cholesterol guidelines) 
  65 
24. 2.2.2 (Proportion of providers who classify LDL, HDL, and total cholesterol 
according to current evidence-based guidelines) 
25. 2.2.4 (Proportion of providers who increase monitoring and shifts in medication for 
patients unable to achieve cholesterol treatment goals) 
26. 2.2.6 (Proportion of patients with high cholesterol who receive provider-initiated 
recommendation and follow-up of therapeutic lifestyle modifications) 
27. 2.2.7 (Proportion of providers who counsel patients with high cholesterol on how to 
take prescribed medicines) 
28. 2.2.8 (Proportion of providers who work with patients to identify cholesterol self 
management goals) 
29. 2.3.1 (Proportion of worksites with employer payment for services to control high 
cholesterol) 
30. 2.5.4 (Proportion of adults who know which therapeutic lifestyle behavior changes 
are associated with controlling high cholesterol) 
31. 2.6.3 (Prevalence of obesity among adults with high cholesterol) 
32. 2.6.4 (Smoking prevalence among adults with high cholesterol) 
33. 2.6.6 (Disparity in risk factors for high cholesterol between general and priority 
populations) 
34. 2.6.8 (Disparity in adherence to cholesterol-lowering medication regimens between 
general and priority populations) 
35. 2.7.2 (Average HDL cholesterol level among adults with high cholesterol) 
36. 2.7.3 (Average triglyceride level among adults with high cholesterol) 
37. 2.7.4 (Average total cholesterol level among adults with high cholesterol) 
38. 2.8.3 (Proportion of adults with high cholesterol who have Non-HDL cholesterol at 
or below goal as defined by current evidence-based guidelines) 
39. 2.8.5 (Disparity in high LDL cholesterol control between general and priority 
populations) 
40. 2.9.2 (Proportion of adults with high cholesterol who have poor quality of life) 
41. 2.9.3 (Prevalence of nonfatal cardiovascular events associated with high cholesterol) 
42. 2.9.4 (Death rate due to cardiovascular disease associated with high cholesterol) 
43. 2.10.1 (Disparity in cardiovascular morbidity associated with high cholesterol 
between general and priority populations) 
44. 2.10.2 (Disparity in cardiovascular mortality associated with high cholesterol 
between general and priority populations) 
45. 2.11.1 (Average annual employer costs attributable to high cholesterol and related 
health outcomes) 
46. 2.11.2 (Average annual outpatient costs attributable to high cholesterol and related 
health outcomes) 
47. 2.11.3 (Average annual inpatient costs attributable to high cholesterol and related 
health outcomes) 
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48. 2.11.4 (Average annual emergency department costs attributable to high cholesterol 
and related health outcomes) 
 
Basic Implementation Program Unused Indicators (Core Indicators are bolded): 
1. 1.2.4 (Proportion of providers who follow JNC pharmacologic guidelines prior to 
initiating therapy) 
2. 1.3.1 (Proportion of worksites with employer payment for services to control high 
blood pressure and cardiovascular risk factors) 
3. 1.3.5 (Proportion of workplaces with on-site clinical health services or physician 
referrals to control high blood pressure) 
4. 1.4.3 (Prevalence of health education activities to control high blood pressure) 
5. 1.5.2 (Proportion of individuals who know what therapeutic lifestyle changes are 
associated with blood pressure control) 
6. 1.5.7 (Number of patients with missed follow-up provider appointments for treatment 
of high blood pressure) 
7. 1.5.8 (Proportion of individuals satisfied with healthcare services) 
8. 1.5.9 (Average annual out-of-pocket patient costs for prescription drugs attributable 
to the treatment of high blood pressure [per person with high blood pressure]) 
9. 1.5.10 (Average annual out-of-pocket patient costs associated with therapeutic 
lifestyle modification for the treatment of high blood pressure [per person with high 
blood pressure]) 
10. 1.6.1 (Disparity in high blood pressure risk factors between general and priority 
populations) 
11. 1.6.5 (Prevalence of obesity) 
12. 1.6.7 (Proportion of individuals adopting the Dietary Approaches to Stop 
Hypertension [DASH] eating plan) 
13. 1.6.8 (Proportion of individuals reporting elevated levels of stress) 
14. 1.6.10 (Disparity between general and priority populations  compliance with high 
blood pressure control regimens) 
15. 1.7.1 (Average blood pressure levels among individuals with high blood pressure) 
16. 1.7.3 (Disparity in blood pressure levels between general and priority populations 
that have been diagnosed with high blood pressure) 
17. 1.9.1 (Proportion of individuals with elevated cardiovascular risk) 
18. 1.9.2 (Average level of quality of life) 
19. 1.9.3 (Proportion of individuals requiring hospitalization/emergency care associated 
with high blood pressure associated outcomes) 
20. 1.9.4 (Prevalence of nonfatal cardiovascular events associated with high blood 
pressure) 
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21. 1.10.1 (Disparity in cardiovascular morbidity associated with high blood pressure 
between general and priority populations) 
22. 1.10.2 (Disparity in cardiovascular mortality between general and priority 
populations) 
23. 1.11.2 (Average annual outpatient costs attributable to high blood pressure and 
related health outcomes [per person with high blood pressure]) 
24. 1.11.3 (Average annual inpatient costs attributable to high blood pressure and 
related health outcomes [per person with high blood pressure]) 
25. 1.11.4 (Average annual costs of emergency room services attributable to high blood 
pressure and related health outcomes [per person with high blood pressure]) 
26. 2.1.1 (Proportion of healthcare systems with policies that identify LDL cholesterol as 
the primary target of lipid-lowering therapy) 
27. 2.1.4 (Proportion of healthcare systems with treatment algorithms that incorporate 
recommendations of current evidence-based cholesterol guidelines) 
28. 2.2.7 (Proportion of providers who counsel patients with high cholesterol on how to 
take prescribed medicines) 
29. 2.2.8 (Proportion of providers who work with patients to identify cholesterol self 
management goals) 
30. 2.3.1 (Proportion of worksites with employer payment for services to control high 
cholesterol) 
31. 2.5.1 (Proportion of adults who have had their cholesterol checked within the 
previous five years) 
32. 2.5.3 (Disparity in knowledge of the risks of high cholesterol between general and 
priority populations) 
33. 2.5.5 (Proportion of adults who are aware of their personal risk associated with high 
cholesterol) 
34. 2.5.6 (Annual out-of-pocket patient coasts for prescription medication for the 
treatment of high cholesterol) 
35. 2.5.7 (Average annual out-of-pocket costs associated with therapeutic lifestyle 
modification for the treatment of high cholesterol) 
36. 2.6.4 (Smoking prevalence among adults with high cholesterol) 
37. 2.6.5 (Proportion of smokers with high cholesterol who have made a quit attempt 
using proven cessation methods) 
38. 2.6.6 (Disparity in risk factors for high cholesterol between general and priority 
populations) 
39. 2.6.8 (Disparity in adherence to cholesterol-lowering medication regimens between 
general and priority populations) 
40. 2.7.1 (Average LDL cholesterol level among adults with high cholesterol) 
41. 2.7.2 (Average HDL cholesterol level among adults with high cholesterol) 
42. 2.7.3 (Average triglyceride level among adults with high cholesterol) 
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43. 2.7.4 (Average total cholesterol level among adults with high cholesterol) 
44. 2.8.2 (Proportion of adults diagnosed with high cholesterol who have LDL 
cholesterol at or below goal as defined by current evidence-based guidelines) 
45. 2.8.5 (Disparity in high LDL cholesterol control between general and priority 
populations) 
46. 2.9.1 (Proportion of adults with high cholesterol who have an elevated 10-year 
cardiovascular risk) 
47. 2.9.2 (Proportion of adults with high cholesterol who have poor quality of life) 
48. 2.9.3 (Prevalence of nonfatal cardiovascular events associated with high cholesterol) 
49. 2.10.1 (Disparity in cardiovascular morbidity associated with high cholesterol 
between general and priority populations) 
50. 2.10.2 (Disparity in cardiovascular mortality associated with high cholesterol 
between general and priority populations) 
51. 2.11.1 (Average annual employer costs attributable to high cholesterol and related 
health outcomes) 
52. 2.11.2 (Average annual outpatient costs attributable to high cholesterol and related 
health outcomes) 
53. 2.11.3 (Average annual inpatient costs attributable to high cholesterol and related 
health outcomes) 
54. 2.11.4 (Average annual emergency department costs attributable to high cholesterol 
and related health outcomes) 
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